S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

TG Therapeutics (TGTX) Short Interest Ratio & Short Volume

$17.22
-0.41 (-2.33%)
(As of 02/29/2024 ET)

TG Therapeutics Short Interest Data

Current Short Volume
35,780,000 shares
Previous Short Volume
29,120,000 shares
Change Vs. Previous Month
+22.87%
Dollar Volume Sold Short
$515.23 million
Short Interest Ratio / Days to Cover
7.2
Last Record Date
February 15, 2024
Outstanding Shares
151,410,000 shares
Float Size
136,400,000 shares
Short Percent of Float
26.23%
Today's Trading Volume
6,197,584 shares
Average Trading Volume
5,322,166 shares
Today's Volume Vs. Average
116%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling TG Therapeutics ?

Sign up to receive the latest short interest report for TG Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TGTX Short Interest Over Time

TGTX Days to Cover Over Time

TGTX Percentage of Float Shorted Over Time


TG Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/202435,780,000 shares $515.23 million +22.9%26.2%7.2 $14.40
1/31/202429,120,000 shares $472.91 million -5.2%21.4%5.6 $16.24
1/15/202430,700,000 shares $484.14 million -3.6%22.5%4.7 $15.77
12/31/202331,830,000 shares $543.66 million -12.8%23.2%5.2 $17.08
12/15/202336,520,000 shares $674.89 million +1.7%26.6%6.3 $18.48
11/30/202335,920,000 shares $460.14 million -1.9%26.2%6.4 $12.81
11/15/202336,610,000 shares $412.59 million -1.1%26.7%6.8 $11.27
10/31/202337,020,000 shares $286.16 million -0.5%27.0%6.8 $7.73
10/15/202337,210,000 shares $248.93 million +14.5%27.2%7.2 $6.69
9/30/202332,510,000 shares $271.78 million +10.2%23.7%6.5 $8.36
9/15/202329,510,000 shares $299.23 million +5.5%21.5%6 $10.14
8/31/202327,970,000 shares $292.85 million +1.6%20.4%5.8 $10.47
8/15/202327,520,000 shares $317.31 million +19.2%20.1%5.8 $11.53
7/31/202323,080,000 shares $477.53 million +3.3%16.9%5 $20.69
7/15/202322,340,000 shares $493.71 million -1.1%16.5%5.7 $22.10
6/30/202322,580,000 shares $560.89 million +0.4%16.7%5.5 $24.84
6/15/202322,480,000 shares $595.27 million +0.2%16.6%5.4 $26.48
5/31/202322,430,000 shares $597.31 million +3.0%16.6%5.2 $26.63
5/15/202321,770,000 shares $678.14 million -15.0%16.1%5.1 $31.15
4/30/202325,610,000 shares $635.90 million -6.7%19.3%5.8 $24.83
4/15/202327,460,000 shares $557.99 million -3.4%20.7%6.6 $20.32
3/31/202328,420,000 shares $427.44 million +6.6%21.5%6.3 $15.04
3/15/202326,650,000 shares $394.15 million +2.6%20.1%4.7 $14.79
2/28/202325,970,000 shares $416.04 million +6.3%19.1%4.6 $16.02
2/15/202324,440,000 shares $472.67 million +4.2%18.1%4.5 $19.34
1/31/202323,450,000 shares $357.14 million +4.0%17.4%4.3 $15.23
1/15/202322,560,000 shares $307.49 million -3.3%16.7%4.4 $13.63
12/30/202223,340,000 shares $276.11 million +12.9%17.3%4.9 $11.83
12/15/202220,680,000 shares $178.26 million +6.9%15.3%7 $8.62
11/30/202219,350,000 shares $170.67 million -1.7%14.4%7.2 $8.82
11/15/202219,680,000 shares $173.38 million +2.3%14.6%7.6 $8.81
10/31/202219,230,000 shares $111.92 million -1.1%14.3%7.9 $5.82
10/15/202219,440,000 shares $105.56 million +5.8%14.5%7.6 $5.43
9/30/202218,380,000 shares $108.81 million +3.8%13.7%7 $5.92
9/15/202217,710,000 shares $129.28 million -3.1%13.2%6.6 $7.30
8/31/202218,270,000 shares $130.27 million -3.5%13.6%6.3 $7.13
8/15/202218,940,000 shares $159.10 million -7.1%14.1%5.9 $8.40
7/31/202220,380,000 shares $122.08 million -2.3%15.3%6.2 $5.99
7/15/202220,860,000 shares $129.33 million +0.2%28.8%6.6 $6.20
6/30/202220,810,000 shares $88.44 million +2.5%28.7%6.3 $4.25













TGTX Short Interest - Frequently Asked Questions

What is TG Therapeutics' current short interest?

Short interest is the volume of TG Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 15th, investors have sold 35,780,000 shares of TGTX short. 26.23% of TG Therapeutics' shares are currently sold short. Learn More on TG Therapeutics' current short interest.

What is a good short interest ratio for TG Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TGTX shares currently have a short interest ratio of 7.0. Learn More on TG Therapeutics's short interest ratio.

Which institutional investors are shorting TG Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of TG Therapeutics: GTS Securities LLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Citadel Advisors LLC, Cubist Systematic Strategies LLC, Capital Fund Management S.A., Hsbc Holdings PLC, IMC Chicago LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, Cutler Group LLC CA, and Citigroup Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for TG Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 26.23% of TG Therapeutics' floating shares are currently sold short.

Is TG Therapeutics' short interest increasing or decreasing?

TG Therapeutics saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 35,780,000 shares, an increase of 22.9% from the previous total of 29,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TG Therapeutics' float size?

TG Therapeutics currently has issued a total of 151,410,000 shares. Some of TG Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TG Therapeutics currently has a public float of 136,400,000 shares.

How does TG Therapeutics' short interest compare to its competitors?

26.23% of TG Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to TG Therapeutics: Alpine Immune Sciences, Inc. (6.94%), PTC Therapeutics, Inc. (13.76%), Maravai LifeSciences Holdings, Inc. (5.82%), Syndax Pharmaceuticals, Inc. (10.14%), Structure Therapeutics Inc. (8.70%), NewAmsterdam Pharma (0.82%), Zai Lab Limited (4.75%), Ardelyx, Inc. (12.92%), Agios Pharmaceuticals, Inc. (13.97%), Janux Therapeutics, Inc. (8.59%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short TG Therapeutics stock?

Short selling TGTX is an investing strategy that aims to generate trading profit from TG Therapeutics as its price is falling. TGTX shares are trading down $0.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TG Therapeutics?

A short squeeze for TG Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TGTX, which in turn drives the price of the stock up even further.

How often is TG Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TGTX, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:TGTX) was last updated on 2/29/2024 by MarketBeat.com Staff